ZEPHYRx offers a cloud-based platform for remote respiratory monitoring, enabling healthcare providers to conduct pulmonary function tests from patients' homes. This solution enhances patient adherence and satisfaction while providing a new revenue stream through reimbursement for chronic respiratory condition management.
Funding
Funding not disclosed
Founders
Product
Problem
Managing chronic respiratory conditions and conducting effective clinical trials require frequent pulmonary function tests, which traditionally involve in-clinic appointments and specialized equipment. This can lead to challenges in patient adherence, reduced frequency of monitoring, and increased costs for both providers and researchers.
Solution
ZEPHYRx offers a decentralized respiratory solution that combines a cloud-based platform with remote spirometry devices, enabling healthcare providers and clinical researchers to conduct pulmonary function tests from patients' homes or point-of-care kiosks. The platform facilitates increased patient satisfaction through convenient remote monitoring and supports improved adherence with innovative features and just-in-time respiratory testing. By providing a cost-effective alternative to in-person pulmonary function tests, ZEPHYRx allows for more frequent monitoring, streamlined workflows, and the potential for improved patient outcomes. The end-to-end solution includes the necessary clinical support to ensure successful service delivery.
Target Audience
The primary target audience includes healthcare providers managing patients with chronic respiratory conditions, clinical researchers conducting respiratory-related studies, and lung transplant centers monitoring patient recovery.
Features
- Cloud-based platform for remote respiratory monitoring
- Point-of-care (Kiosk) and at-home (Home) testing solutions
- Real-time video coaching for clinical teams to interact with patients during pulmonary function tests
- Integration with ActiGraph wearable technology for comprehensive data collection
- Support for various respiratory conditions, including COPD, cystic fibrosis, pulmonary fibrosis, and asthma
- Data sharing capabilities for seamless collaboration between patients and healthcare teams
- Integration with Target ALS's Data Engine for ALS research
- Integration of ZEPHYRx and ActiGraph endpoints into a single, centralized platform